Announcements

American Journal of Tropical Medicine and Hygiene Publishes Recommendations for Safe and Ethical Testing of Gene Drive Mosquitoes to Reduce Malaria Transmission in Africa

June 7, 2018 — The American Journal of Tropical Medicine and Hygiene (AJTMH) has published an article outlining recommendations for the safe and ethical testing of gene drive technology on mosquitoes to reduce the burden of malaria transmission in Africa.

Read More

Q&A with Lawrence Schwartz, M.D., Columbia University Medical Center: Vol-PACT Project Expansion Initiates Analysis of Cancer Tumor Growth with Novel Measurement Technique

May 8, 2018 — Since 2017, the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) has been developing new methods for analyzing digital images that can help track a patient’s response to cancer therapy. Housed within the BC’s Cancer Steering Committee, the project called “Advanced metrics and modeling with Volumetric CT for Precision Analysis of Clinical Trial results” (Vol-PACT) has the potential to accelerate the creation of cancer therapies and to improve treatment options for patients.

Read More

The FNIH Biomarkers Consortium Launches Project to Improve Diagnosis and Treatment of Neurodegenerative and Psychiatric Diseases

April 26, 2018 The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a project, under its Neuroscience Steering Committee, with the potential to improve diagnosis and the development of targeted therapies for Alzheimer’s Disease (AD) and Major Depressive Disorder (MDD).

Read More

Driven to Cure, Inc. Donates an Additional $100,000 to the Foundation for the National Institutes of Health to Further Cutting-Edge Research on Rare Kidney Cancer

December 14, 2017 — Driven to Cure, Inc. has donated an additional $100,000 to the Foundation for the National Institutes of Health (FNIH) to further cutting-edge research on rare kidney cancer conducted by the National Cancer Institute (NCI) at the National Institutes of Health (NIH) Clinical Center.

Read More

Science Translational Medicine Publishes Article on Evidence Needed for Biomarker Qualification

December 7, 2017 — Science Translational Medicine has published an article by experts from the Foundation for the National Institutes of Health, the National Institutes of Health, the U.S. Food and Drug Administration (FDA), industry, academia and not-for-profit organizations that outlines a framework for the level of evidence needed to support qualification of biological markers (biomarkers) for use in drug development decision making. While biomarkers can facilitate all aspects of drug development, their use has been hampered by lack of a clear and predictable process to qualify new markers with the FDA.

Read More

Science Publishes Guiding Principles for Sponsors and Supporters of Gene Drive Research

November 30, 2017 — Science has published an article outlining guiding principles for sponsors and supporters of gene drive research agreed upon by 13 organizations thus far, including the Foundation for the National Institutes of Health. Considered an emerging technology still in early research, gene drive can be used to promote the preferential inheritance of a beneficial trait, thereby increasing its prevalence in a population.

Read More

Q&A with Michael Gottlieb, Ph.D., FNIH Deputy Director of Science: The Significant Role of Malnutrition, Intestinal Infection and Disease on Child Development

October 11, 2017 — For almost a decade, the Foundation for the National Institutes of Health (FNIH), in collaboration with the National Institutes of Health’s Fogarty International Center (FIC), has managed the most comprehensive multicenter study to better understand the complicated relationships among intestinal infections, nutrition and other environmental exposures early in life on child development. “The Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development” (MAL-ED) study, supported by a grant from the Bill & Melinda Gates Foundation, captured the significant burden that such exposures have on the health, physical growth and cognitive development of children from birth to early childhood at eight sites in Africa, Asia and South America.

Read More

The FNIH Biomarkers Consortium Launches Project to Improve Monitoring of Early Alzheimer’s Disease Progression and Treatment Response

August 16, 2017 — The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium (BC) has launched a project with the potential to transform clinical trials and lead to the development of targeted therapies for Alzheimer’s disease (AD) patients. The Cerebrospinal Fluid (CSF) Proteomics Project leverages results from a previous BC project to analyze potential biological markers (biomarkers) that can track AD in its earliest stages by illuminating important changes in the brain. This new understanding of AD progression will help improve the monitoring of early AD and a patient’s response to treatment.

Read More

FNIH Rated #1 Charity among Biomedical Research Organizations by Charity Navigator

July 27, 2017 — The Foundation for the National Institutes of Health (FNIH) is delighted to once again earn the highest, 4-star rating from Charity Navigator, in addition to being named the #1 charity among biomedical research organizations.

Read More

The FNIH Biomarkers Consortium Launches Study to Identify Cardiovascular Risk in Rheumatoid Arthritis Patients

July 20, 2017 The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a study to identify biological markers (biomarkers) in the blood that will measure a Rheumatoid Arthritis (RA) patient’s increased risk for cardiovascular disease—the leading cause of deaths in RA patients. RA is a chronic inflammatory disease that causes pain and loss of mobility, and by developing therapies that decrease joint inflammation it may also reduce cardiovascular risk.

Read More